These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3087922)

  • 1. Functional characterization of infiltrating T lymphocytes in human hepatic allografts.
    Fung JJ; Zeevi A; Starzl TE; Demetris J; Iwatsuki S; Duquesnoy RJ
    Hum Immunol; 1986 Jun; 16(2):182-99. PubMed ID: 3087922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
    Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
    Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propagation and characterization of lymphocytes from transplant biopsies.
    Duquesnoy RJ; Trager JD; Zeevi A
    Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of cytotoxic cells derived from endomyocardial biopsies in human cardiac allografts.
    Trentin L; Zambello R; Faggian G; Livi U; Thiene G; Gasparotto G; Agostini C
    Cell Immunol; 1992 May; 141(2):332-41. PubMed ID: 1374288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.
    Zeevi A; Fung J; Zerbe TR; Kaufman C; Rabin BS; Griffith BP; Hardesty RL; Duquesnoy RJ
    Transplantation; 1986 May; 41(5):620-6. PubMed ID: 3085298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance.
    Kirk AD; Ibrahim MA; Bollinger RR; Dawson DV; Finn OJ
    Transplantation; 1992 Feb; 53(2):329-38. PubMed ID: 1371194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers.
    Bishop GA; Hall BM; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
    Kidney Int; 1986 Mar; 29(3):708-17. PubMed ID: 2939279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
    Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HLA class I and class II antigens in activation and differentiation of B cells.
    Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S
    Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
    Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
    Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.
    Chauhan B; Phelan DL; Marsh JW; Mohanakumar T
    Transplantation; 1993 Aug; 56(2):443-8. PubMed ID: 7689260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human allograft-derived T-cell lines: donor class I- and class II-directed cytotoxicity and repertoire stability in sequential biopsies.
    Miceli MC; Barry TS; Finn OJ
    Hum Immunol; 1988 Jul; 22(3):185-98. PubMed ID: 3139590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific cellular immune response against human cardiac valve allografts.
    Hoekstra F; Knoop C; Vaessen L; Wassenaar C; Jutte N; Bos E; Bogers A; Weimar W
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):281-6. PubMed ID: 8751491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.